Background: Midface fractures can cause airway obstruction and breathing distur bances. The purpose of the present study was to determine the prevalence of undiag nosed obstructive sleep apnea (OSA) among patients with surgically treated maxillary and zygomatic fractures.
M
axillofacial fractures may result from a variety of injury types. The diagnosis and treatment of these injuries frequently require a multidisci plinary team approach. Zygomatic fractures are the second most common facial fractures, after nasal frac tures. 1 Mandibular and zygomatic bone fractures account for 80% of all facial bone fractures, and maxillary fractures account for 5%. 1 The outcomes of maxillofacial trauma are of great significance, both functionally and aesthet ically. 1, 2 The best aesthetic and functional outcomes are obtained with early rigid fixation with screws and plates. 2, 3 Functionally, skeletal factors, which are usually not readily apparent on physical examination, may be important determinants of upperairway patency during wakefulness but also during sleep. 4, 5 Among sleeprelated breathing disorders, according to studies in the general population, 6 obstructive sleep apnea (OSA) has emerged as a highly prevalent breathing disor der, affecting 3%-7% of adult men and 2%-5% of adult women. 7 Obstructive sleep apnea arises from a combina tion of pathophysiological and anatomic factors, resulting in narrowing of the upper airway. The exact levels of obstruction may vary from one person to another. Invasive and noninvasive methods can be used to identify and evalu ate the level of obstruction, but some (e.g., magnetic resonance imaging and fibroscopy) are too expensive and too invasive to be used in field surveys. Therefore, the clas sical sleep questionnaires, anthropometric measurements and simple nose-throat examinations, which are readily accepted by patients, are useful for the identification of those at increased risk for OSA. 8 Patients who have undergone surgical treatment of maxillary or zygomatic fractures may have upper airway abnormalities related to the fracture and to the surgical procedure. Regular screening for OSA in these patients by means of standard questionnaires such as the STOP (snor ing, tiredness, observed apnea and high blood pressure) questionnaire, the STOPBang questionnaire and the recently developed Nasal Obstruction Symptom Evalua tion (NOSE) scale 9-12 may be of additional value. The aim of the present study was to determine the prevalence of undiagnosed OSA among patients with surgically treated maxillary and zygomatic fractures. Also, we wanted to explore whether clinical data and NOSE scale scores can be used to identify those at increased risk for OSA in this population.
Methods

Setting and participants
In this retrospective cohort study, we reviewed the medical records of male patients aged 18 years or more who had undergone surgical treatment of maxillary or zygomatic fractures between Jan. Patients who met the diagnostic and treatment criteria were contacted by letter or telephone, and those willing to participate were recruited for the study.
This study was approved by the Ethics Committee of the University of Split School of Medicine and the Univer sity Hospital Center Split and was undertaken in agree ment with the principles of the Declaration of Helsinki. All participants signed written informed consent before participation.
Sleep assessment
All participants underwent unattended wholenight poly graphy testing. The device used in this study to identify participants with OSA was the Embletta portable diagnos tic system (Medcare). This system is highly sensitive and specific in quantifying the Apnea-Hypopnea Index (AHI) and has been validated as a screening and diagnostic tool for OSA. 13 We defined apnea as complete cessation of respiratory airflow for a minimum of 10 seconds and hypopnea as a decrease in airflow by more than 50% from baseline for at least 10 seconds, combined with a reduction in hemoglobin oxygen saturation of at least 3%. [14] [15] [16] We defined the AHI as the average number of apneic and hypopneic events per hour of sleep, and we calculated the oxygen desaturation index as the number of decreases in arterial oxygen saturation of 3% or more per hour of sleep. [14] [15] [16] We used the AHI to quantify the severity of OSA as follows: AHI 5-14.9: mild OSA; 15 ≤ AHI ≤ 30: moderate OSA; and AHI > 30: severe OSA.
All data were manually scored and evaluated in accor dance with published guidelines of the American Academy of Sleep Medicine and the European Sleep Research Soci ety [14] [15] [16] by the same certified sleep physician, who was blind to the participants' involvement in the study. The data were analyzed if the total recorded time was 4 hours or longer.
Questionnaires
Demographic and anthropometric characteristics (e.g., age, body mass index, neck circumference) were collected at the Split Sleep Medicine Center before the wholenight sleep assessment. Participants were asked to complete the STOP questionnaire, NOSE scale and Epworth Sleepiness Scale (ESS). The STOP question naire is 4item selfreported questionnaire that has been shown to be a concise, easytouse screening tool for iden tifying patients who are at increased risk for OSA (≥ 2 positive answers). 9 The NOSE scale is a validated diseasespecific instrument designed to measure nasal obstruction, commonly used in otolaryngology practice to provide an objective measure of nasal obstruction. 10, 12 It consists of 5 selfrated items, each scored from 0 to 4.
10
The NOSE scale score represents the sum of the scores for the responses to the 5 individual items and ranges from 0 (no nasal obstruction) to 100 (worst possible prob lems caused by nasal obstruction). 10 The ESS is a self administered questionnaire used to evaluate the level of daytime sleepiness. 17 Patients are asked to rate their chance of falling asleep during 8 routine daytime situa tions on a scale of 0-3. The final score is the total score for the 8 items and ranges from 0 to 24, with the cutoff value of 9 suggesting the presence of excessive daytime sleepiness. 18 The Croatian versions of the STOP questionnaire and ESS have been validated. 18 
Statistical analysis
We performed statistical analyses using MedCalc for Win dows version 11.5.1.0 (MedCalc Software). Continuous data were presented as mean and standard deviation (SD), and categorical variables were presented as whole numbers and proportions. We determined differences in variables between groups using the Mann-Whitney test for independent sam ples and the χ 2 test. We evaluated correlations between study variables and AHI using Spearman's rank correlation coefficients. Statistical significance was set at p < 0.05.
Results
The study population consisted of 44 participants, 27 (61%) with maxillary fractures and 17 (39%) with zygo matic complex fractures. None of the participants had mal occlusion or rhinoseptoplasty in the postoperative period. Of the 27 participants with maxillary fractures, 8 had Le Fort I fractures, 8 had Le Fort II fractures, 4 had Le Fort III fractures, and 7 had a combination of 2 differ ent patterns. The baseline demographic and anthropomet ric characteristics of the participants are presented in Table 1 . There were no statistically significant differences between those with maxillary fractures and those with zygomatic complex fractures.
All participants had at least 4 hours of recorded time on polygraphy testing. The sleep characteristics of the partici pants are presented in Table 2 . There were no statistically significant differences between those with maxillary frac tures and those with zygomatic fractures. In addition, the questionnaire scores did not differ significantly between the 2 groups (Table 3) . Therefore, we decided to unify the 2 groups of participants into 1 group for further analyses.
Obstructive sleep apnea was diagnosed in 24 partici pants (54%). There were 14 participants (32%) with mild OSA, 7 (16%) with moderate OSA and 3 (7%) with severe OSA. Of the 24, 15 (62%) had maxillary fractures and 9 (38%) had zygomatic fractures. The participants with OSA differed significantly from those without OSA in mean age (49. Table 4 ). The par ticipants with OSA had a mean AHI of 15.5 (SD 9.7) events/h, compared to 2.4 (SD 1.5) events/h for those without OSA (p < 0.001). The corresponding oxygen desaturation index values were 11.6 (SD 8.9) events/h and 1.9 (SD 1.2) events/h (p = 0.002). Thirtyfive participants (80%) had no risk for OSA, as estimated by the STOP questionnaire (Table 4) . Of the 35, 19 did not have OSA according to the sleep study data. According to the STOP questionnaire, 9 participants (20%) had increased risk for OSA, and OSA was confirmed in 8 (89%) of them during polygraphy testing.
The NOSE scale results showed that 30 participants (68%) had nose obstruction and 14 (32%) did not (Table 5) . Of the 30 participants with nose obstruction, 18 (60%) had an AHI of 5 or greater. Only 6 (25%) of the 24 participants with OSA had no nose obstruction accord ing to the NOSE scale. Significant correlations were found between the AHI and the NOSE scale score (r = 0.323, p = 0.04) when we performed analysis on the overall study population ( Table 6) .
Five of the participants with OSA experienced excessive daytime sleepiness, with a mean ESS score of 11.6 (SD 1.8). Of the 5, 2 had a STOP score of 2 or greater, and 4 had nasal obstruction, estimated by the NOSE scale. Only 1 participant in the nonOSA group had excessive daytime sleepiness according to the ESS score.
discussion
In this retrospective analysis of the prevalence of OSA, nasal obstruction and daytime sleepiness in a sample of 44 participants with surgically treated maxillary or zygo matic fractures, the prevalence of OSA was higher in our study population than in general population. 7, 19, 20 The use of questionnaires as a screening tool for OSA proved to be a valuable, but special attention should be paid when using the STOP questionnaire in specific popu lations, since in our participants with midface injury it was unable to identify risk in a substantial proportion of those with confirmed OSA. The NOSE scale showed good correlation with the presence of OSA: 75% of par ticipants with OSA reported nose obstruction according to this scale. Nasal obstruction has been identified as a risk factor for OSA and is a common sign in patients with the disorder. 12, 21, 22 Obstructive sleep apnea is prevalent in surgical popula tions and is considered to be an independent risk factor for perioperative complications in noncardiac opera tions. 23 Surgical patients with OSA are vulnerable to seda tion, anesthesia and analgesia. The perioperative risk of patients with OSA may be reduced by appropriate screen ing to detect undiagnosed OSA and to plan a specific peri operative management plan for those with OSA. 24 There fore, it is important to identify patients at high risk for OSA preoperatively, which is not always easy. The short interval between the preoperative clinic visit and sched uled surgery date, lack of patient willingness to undergo preoperative polysomnography or polygraphy testing and potentially long wait times for a sleep clinic appointment may hinder the diagnosis of OSA before surgery. By incorporating the STOP or STOPBang questionnaire and the NOSE scale into preoperative clinic practice, sur gical patients at risk for OSA can be better detected, which can help during their perioperative and postopera tive treatment. 25 The STOP questionnaire has been validated in sur gical patients at preoperative clinics. 9 In our study popu lation, the STOP questionnaire proved to have good pre dictive value to detect participants with OSA: the disorder was confirmed during polygraphy testing in 89% of patients who had a STOP score of 2 or greater. In the study by Chung and colleagues, 9 the STOP ques tionnaire administered preoperatively to surgical patients had a sensitivity of 65.6%, 74.3% and 79.5% with AHI cutoff values of greater than 5 events/h, greater than 15 events/h and greater than 30 events/h, respectively. In addition, an earlier study from our group showed a high level of sensitivity and specificity of the STOP question naire in patients referred to the Split Sleep Medicine Center. 18 The probability that the STOP questionnaire correctly predicted an AHI greater than 5 events/h was 84%, with a sensitivity of 96% and a specificity of 83% at a cutoff point of 2 events/h for determining the risk of OSA. Our unpublished research on around 4000 partici pants in the general population residing in the same region as those in the current study showed the risk of OSA to be 15.6% in participants aged 31-40 and 25.8% in those aged 41-50, substantially lower than the propor tion of participants with confirmed OSA in the present study, 54% (24/44).
The ESS scores of both participants with OSA and those without OSA in the current study were lower than those in the study by Pecotic and colleagues. 18 This means that people with surgically treated midface injury either experienced less excessive daytime sleepiness or ignored it and reported fewer signs.
Limitations
We did not have any data on nose obstruction, snoring or risk of OSA in our study population before the midface trauma. However, we believe that our results support screening for OSA with the STOP questionnaire, STOP Bang questionnaire and NOSE scale, as well as use of the ESS for assessing excessive daytime somnolence, in sur gical populations to avoid perioperative and postoperative complications. However, caution must be used when interpreting our results owing to possibility of a large pro portion of falsenegative results in this specific population compared to the general population referred to sleep centres.
conclusion
The NOSE scale showed significant correlation with the presence of OSA. Therefore, we recommend its use in common otolaryngology and surgical practice. Specific questionnaires such as the STOP questionnaire used in this study may underestimate the risk of OSA in patients with surgically treated midface fractures, and the ESS may underestimate excessive daytime somnolence. In general, we recommend use of all those questionnaires, but special attention should be paid when they are used in specific sur gical populations, such as patients with surgically treated midface injuries. Finally, the prevalence of OSA was higher in surgical patients with midface fractures regardless of the type of fracture, maxillary or zygomatic, than in the general population.
